Aim-To analyse the expression of heat shock protein (HSP) 60 in biliary epithelium in auto-immune liver conditions and also in chronic cholestatic and other liver diseases.
Heat shock proteins (HSPs) are a highly conserved group of proteins present in all prokaryotic and eukaryotic cells. Their name derives from original experiments in which these proteins were induced in cells exposed to extreme heat.'-' It is now known that they respond to many environmental stresses such as temperature changes, fever, inflammation, irradiation, viral infection, malignant transformation, exposure to heavy metal ions, ethanol, and anoxia.' It has been suggested, therefore, that they should be called stress related proteins. Their Bile ducts strongly positive for HSP-60 were analysed further using confocal laser scanning microscopy (CLSM). The light microscopy sections were used as alkaline phosphatase-fast red is a good fluorescent label for CLSM. '7 This technique permits the study of epitope distribution by focusing on a single plane within the tissue section with enhanced contrast and resolution, compared with light microscopy. Individual planes may then be reconstructed to give an impression of the entire cellular distribution of HSP-60 immunoreactivity. This study conformed to the guidelines of the Central Oxfordshire Health Authority Research Ethics Committee (COREC). Informed consent for liver biopsy was obtained from each patient.
Results

EXPRESSION OF HSP-60 IN BILE DUCTS
Epithelial cytoplasmic expression of HSP-60 was present in the septal bile ducts in all biopsy specimens, including normal liver; in normal liver, however, the staining intensity was much weaker than that observed in the diseased tissue ( Infiltrating portal and lobular cells were strongly positive for HSP-60, as were mononuclear cells and granulocytes. Again, the staining pattern was cytoplasmic and intensely granular. This was confirmed on CLSM. In some areas the staining intensity of the inflammatory infiltrate was stronger than that of the bile ducts and hepatocytes. Discussion HSPs are among the most conserved proteins in nature. They are found in all eukaryotic and prokaryotic cells. Their functions vary among different families, with HSP-60 being responsible for protein folding and oligomerisation. HSPs are also involved in removing damaged proteins from cells and in mediating receptor activation, as in the case of HSP-90 and the steroid receptor. In all cells they are essential for maintaining viability under unfavourable circumstances. Most HSPs exist in small quantities in each cell, but they can be induced by various forms of stress, when their intracellular content is greatly increased. In these instances they can be detected using immunohistochemical methods. Most antibacterial defences include reactions directed against HSPs. Accordingly, because of their shared homology with bacterial proteins-HSP-60 shares more than 50% sequence homology with the GroEL protein of E coli-it has been hypothesised that this may result in autoimmune reactions due to molecular mimicry. '8 This hypothesis is supported mainly by data from studies on rheumatoid and reactive arthritis.91019 This evidence, however, is still inconclusive. 20 In the present study increased expression of HSP-60 was detected in the biliary epithelium of patients with PSC, PBC and LDO. The human homologue of mycobacterial HSP-60 is a mitochondrial protein,7 and the pattern of staining we detected in biliary epithelium was granular and cytoplasmic. Nuclear staining was not observed. This distribution is consistent with the previously described mitochondrial location of HSP-60. A similar pattern of staining has been reported in other studies using the ML30 antibody."
Recently, Broome et all2 reported induced expression of HSP-60 in biliary epithelium in patients with PSC and PBC. In their study there was also some degree ofbiliary expression of HSP-60 in ALD and chronic hepatitis C, but to a much lesser extent than in PSC and PBC. The same group reported the absence of biliary expression of HSP-60 in normal liver tissue. In view of these results it was suggested that this phenomenon could be directly involved in the auto-immune genesis of PSC and PBC. As bile ducts in PSC and PBC also aberrantly express HLA-DR,"22 it is possible that these cells act as antigen presenting cells and HSP-60 could be the putative auto-antigen. In the present study, however, enhanced expression of HSP-60 was detected in the bile ducts of patients with LDO as well in those with PSC and PBC. These findings suggest that enhanced expression of HSP-60 in bile ducts may not have a primary role in biliary auto-immunity. In the patients with LDO presented herein, extra hepatic duct obstruction was caused by a variety of conditions, none of which were immune mediated. Moreover, nonspecific aberrant expression of HIA-DR has also been demonstrated in LDO.2'22 If HIA-DR positive bile ducts present HSP-60 as an auto-antigen, one would expect manifestations of auto-immunity to occur in LDO as well as in PBC and PSC. As yet, there is no evidence to suggest that auto-immune bile duct damage occurs in LDO. Therefore, as HSPs are known to respond to a variety of stresses, it is likely that HSP-60 expression is induced non-specifically in bile ducts exposed to a variety of chronic noxious stimuli, such as chronic cholestasis, and that this is a secondary phenomenon, rather than a primary event. The intensity of the staining of the inflammatory infiltrate and Kupffer cells in LDO also suggests that the HSP-60 response is non-specific. If HSP-60 is an auto-antigen, one would expect that these cells, in view of their high HSP content, would become targets of an autoimmune reaction. At present, this does not appear to be the case. Another possibility is cross-reaction between the ML30 antibody and bacterial HSP, as these patients are more prone to biliary colonisation. This is unlikely, however, as although the ML30 epitope in mycobacteria and humans is homologous, it is not widely shared among bacteria. 23 Expression of HSP-60 may be involved in the pathogenesis of PSC via an alternative mechanism. Anderson et al24 demonstrated that cross-reactivity in the immune response to the mycobacterial HSP-60 can be directed against self proteins, such as HLA-DR2. Also, human CD8 + T cells have been shown to recognise mycobacterial antigens in a HLA-B8 restricted presentation.25 Interestingly, both HLA-B8 and DR2 are strongly associated with PSC. Therefore, although HSP-60 expression was not unique to PSC, this HSP may induced autoimmune liver damage in genetically susceptible individuals. If this was the case, the auto-immune response would therefore be constrained by the expression of HIA antigens. This may also be the case for PBC but, as yet, this condition has not been closely associated with expression of a particular HLA antigen.
HSP-60 was highly expressed by hepatocytes in tissue samples from patients with LDO, PBC, PSC, AIH, and ALD. This expression is also presumably non-specific, a supposition supported by the non-specific increase in circulating antibodies directed against HSP-60 in ALD, PBC and PSC.14 Similar data has been reported by Lohse et al,26 who found increased hepatocytic expression of HSP-60 in fatty livers, and viral and auto-immune hepatitis, diseases with a very different aetiopathogenesis.
In conclusion, the results reported here suggest that the enhanced biliary expression of HSP-60 is a non-specific phenomenon, characteristic of a variety of cholestatic liver diseases, and is not a primary event solely associated with auto-immune liver diseases. The role of HSP-60 in biliary auto-immunity has yet to be determined. 
